Someday, diabetics might be able to avoid insulin injections by taking an unlikely combination of an anticholesterol drug and a pain medication to control blood sugar. CombinatoRx of Cambridge, MA, has eight such counterintuitive but synergistic drug combinations in clinical trials, including the examples listed below. The company tests combinations of several thousand drugs at several different doses on cellular models of diseases. The reasons for the synergies are poorly understood; disparate drugs may act on the same molecular pathways.
The hype around DeepMind’s new AI model misses what’s actually cool about it
Some worry that the chatter about these tools is doing the whole field a disservice.
These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.
A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.